Neuronetics Statistics
Total Valuation
Neuronetics has a market cap or net worth of $33.17 million. The enterprise value is $56.03 million.
Important Dates
The next confirmed earnings date is Tuesday, November 12, 2024, before market open.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Neuronetics has 30.30 million shares outstanding. The number of shares has increased by 6.02% in one year.
| Current Share Class | 30.30M |
| Shares Outstanding | 30.30M |
| Shares Change (YoY) | +6.02% |
| Shares Change (QoQ) | +1.97% |
| Owned by Insiders (%) | 6.79% |
| Owned by Institutions (%) | 39.86% |
| Float | 24.12M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.49 |
| Forward PS | 0.42 |
| PB Ratio | 1.85 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.78 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.58, with a Debt / Equity ratio of 3.23.
| Current Ratio | 2.58 |
| Quick Ratio | 2.17 |
| Debt / Equity | 3.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.90 |
Financial Efficiency
Return on equity (ROE) is -100.13% and return on invested capital (ROIC) is -19.87%.
| Return on Equity (ROE) | -100.13% |
| Return on Assets (ROA) | -16.90% |
| Return on Capital (ROIC) | -19.87% |
| Revenue Per Employee | $355,000 |
| Profits Per Employee | -$159,966 |
| Employee Count | 203 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 2.31 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.00% in the last 52 weeks. The beta is 2.22, so Neuronetics's price volatility has been higher than the market average.
| Beta (5Y) | 2.22 |
| 52-Week Price Change | -15.00% |
| 50-Day Moving Average | 0.89 |
| 200-Day Moving Average | 2.30 |
| Relative Strength Index (RSI) | 73.01 |
| Average Volume (20 Days) | 189,073 |
Short Selling Information
The latest short interest is 711,076, so 2.35% of the outstanding shares have been sold short.
| Short Interest | 711,076 |
| Short Previous Month | 564,038 |
| Short % of Shares Out | 2.35% |
| Short % of Float | 2.95% |
| Short Ratio (days to cover) | 2.00 |
Income Statement
In the last 12 months, Neuronetics had revenue of $72.07 million and -$32.47 million in losses. Loss per share was -$1.11.
| Revenue | 72.07M |
| Gross Profit | 54.70M |
| Operating Income | -26.66M |
| Pretax Income | -27.54M |
| Net Income | -32.47M |
| EBITDA | -24.65M |
| EBIT | -26.66M |
| Loss Per Share | -$1.11 |
Full Income StatementBalance Sheet
The company has $42.64 million in cash and $62.62 million in debt, giving a net cash position of -$19.98 million or -$0.66 per share.
| Cash & Cash Equivalents | 42.64M |
| Total Debt | 62.62M |
| Net Cash | -19.98M |
| Net Cash Per Share | -$0.66 |
| Equity (Book Value) | 19.39M |
| Book Value Per Share | 0.64 |
| Working Capital | 46.25M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$24.98 million and capital expenditures -$2.42 million, giving a free cash flow of -$27.40 million.
| Operating Cash Flow | -24.98M |
| Capital Expenditures | -2.42M |
| Free Cash Flow | -27.40M |
| FCF Per Share | -$0.90 |
Full Cash Flow StatementMargins
Gross margin is 75.91%, with operating and profit margins of -37.00% and -45.06%.
| Gross Margin | 75.91% |
| Operating Margin | -37.00% |
| Pretax Margin | -45.06% |
| Profit Margin | -45.06% |
| EBITDA Margin | -34.20% |
| EBIT Margin | -37.00% |
| FCF Margin | -42.81% |
Dividends & Yields
Neuronetics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.02% |
| Shareholder Yield | -6.02% |
| Earnings Yield | -90.07% |
| FCF Yield | -75.99% |
Analyst Forecast
The average price target for Neuronetics is $4.67, which is 326.48% higher than the current price. The consensus rating is "Buy".
| Price Target | $4.67 |
| Price Target Difference | 326.48% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 16.58% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Neuronetics has an Altman Z-Score of -4.74 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.74 |
| Piotroski F-Score | 3 |